Table 5.
Comparison of demographic and clinical baseline data between asymptomatic infection, mild, and moderate groups combined and severe and critical groups combined.
| Asymptomatic infection, mild, and moderate groups combined | Severe and critical groups combined | Z/t/χ 2 | P | |
|---|---|---|---|---|
| Age | 55.50 (42.25, 66.00) | 68.00 (58.25, 75.75) | −4.331 | 0.000 |
| Gender (F/M) | 80/64 | 22/18 | 0.004 | 0.950 |
| Hypertension (Y/N) | 44/100 | 14/26 | 0.286 | 0.592 |
| Diabetes (Y/N) | 16/128 | 8/32 | 2.181 | 0.140 |
| Number of comorbidities | 1 (0, 2) | 3 (1, 4.75) | −4.529 | 0.000 |
| WBC | 5.27 (3.99, 6.78) | 4.85 (3.79, 5.87) | −1.225 | 0.221 |
| NEUT% | 61.55 (53.95, 69.33) | 75.8 (66.95, 85.08) | −5.249 | 0.000 |
| LYMPH | 1.35 (0.99, 1.69) | 0.65 (0.42, 0.99) | −6.403 | 0.000 |
| LYM% | 26.82 ± 9.71 | 15.85 ± 8.99 | 6.424 | 0.000 |
| RDW | 40.8 (38.50, 42.88) | 41.55 (38.00, 43.93) | −0.426 | 0.670 |
| PLT | 198.00 (149.75, 238.75) | 148.00 (121.50, 209.25) | −2.668 | 0.008 |
| CRP | 6.30 (1.70, 14.48) | 35.49 (20.90, 68.05) | −7.012 | 0.000 |
| ALT | 25.37 (17.55, 36.78) | 28.61 (18.15, 38.70) | −0.685 | 0.494 |
| AST | 23.36 (18.00, 34.17) | 32.94 (20.50, 51.67) | −2.873 | 0.004 |
| SCr | 62.08 (52.45, 73.16) | 63.79 (51.10, 86.28) | −0.609 | 0.542 |
| ALB | 40.60 ± 5.09 | 34.85 ± 5.75 | 6.152 | 0.000 |
| TB | 8.10 (5.93, 10.98) | 11.00 (7.74, 16.41) | −3.940 | 0.000 |
| DBIL | 1.85 (0.00, 3.00) | 2.65 (0.00, 4.68) | −1.600 | 0.110 |
| IBIL | 6.77 (4.20, 8.78) | 8.455 (5.67, 12.48) | −2.898 | 0.004 |
| D-dimer | 0.69 (0.52, 0.94) | 1.17 (0.67, 3.01) | −4.284 | 0.000 |
| LCR | 2,407.47 (640.31, 8,755.06) | 140.42 (71.32, 420.27) | −7.621 | 0.000 |
| SOFA score | 0 (0, 1) | 3 (2, 5) | −8.721 | 0.000 |